Hennige, Anita M.

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 282

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

le Roux, C. W., Steen, O., Lucas, K. J., Startseva, E., Unseld, A., & Hennige, A. M. (2024) · The Lancet Diabetes & Endocrinology

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 237

The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study

Tschritter, O., Preissl, H., Hennige, A. M., Stumvoll, M., Porubska, K., Frost, R., Marx, H., Klösel, B., Lutzenberger, W., Birbaumer, N., et al. (2006) · Proceedings of the National Academy of Sciences

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 223

Evidence for altered transport of insulin across the blood–brain barrier in insulin-resistant humans

Heni, M., Schöpfer, P., Peter, A., Sartorius, T., Fritsche, A., Synofzik, M., Häring, H.-U., Maetzler, W., & Hennige, A. M. (2014) · Acta Diabetologica

Barrier Structure and Function StudiesAdipokines, Inflammation, and Metabolic Diseases

Cited by 158

Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

Blüher, M., Rosenstock, J., Hoefler, J., Manuel, R., & Hennige, A. M. (2024) · Diabetologia

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 138

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models

Allesøe, R. L., Lundgaard, A. T., Hernández Medina, R., Aguayo-Orozco, A., Johansen, J., Nissen, J. N., Brorsson, C., Mazzoni, G., Niu, L., Biel, J. H., et al. (2023) · Nature Biotechnology

Bioinformatics and Genomic NetworksComputational Drug Discovery Methods

Cited by 111

Monounsaturated fatty acids prevent the aversive effects of obesity on locomotion, brain activity, and sleep behavior

Sartorius, T., Ketterer, C., Kullmann, S., Balzer, M., Rotermund, C., Binder, S., Hallschmid, M., Machann, J., Schick, F., Somoza, V., et al. (2012) · Diabetes

Fatty Acid Research and HealthRegulation of Appetite and Obesity

Cited by 73

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906

Jungnik, A., Arrubla Martinez, J., Plum‐Mörschel, L., Kapitza, C., Lamers, D., Thamer, C., Schölch, C., Desch, M., & Hennige, A. M. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 63

BK channels affect glucose homeostasis and cell viability of murine pancreatic beta cells

Düfer, M., Neye, Y., Hörth, K., Krippeit-Drews, P., Hennige, A., Widmer, H., McClafferty, H., Shipston, M. J., Häring, H.-U., Ruth, P., et al. (2011) · Diabetologia

Pancreatic function and diabetesIon channel regulation and function

Cited by 50

The Insulin Effect on Cerebrocortical Theta Activity Is Associated with Serum Concentrations of Saturated Nonesterified Fatty Acids

Tschritter, O., Preissl, H., Hennige, A. M., Sartorius, T., Grichisch, Y., Stefan, N., Guthoff, M., Düsing, S., Machann, J., Schleicher, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 42

Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity

Hennige, A. M., Sartorius, T., Lutz, S. Z., Tschritter, O., Preissl, H., Hopp, S., Fritsche, A., Rammensee, H.-G., Ruth, P., & Häring, H.-U. (2009) · Diabetologia

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 41

Perspectives in weight control in diabetes - survodutide

Klein, T., Augustin, R., & Hennige, A. M. (2024) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 25

51-OR: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BI 456906 in People with Overweight/Obesity

LE ROUX, C., STEEN, O., LUCAS, K. J., STARTSEVA, E., UNSELD, A., & HENNIGE, A. M. (2023) · Diabetes

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 24